приклади
Eskola and colleagues reported the results of a large, randomized, double-blind trial in Finland to test the ability of a heptavalent pneumococcal conjugate vaccine to prevent acute otitis media.
The U.S. Food and Drug Administration recently approved the labeling of a new conjugate heptavalent pneumococcal vaccine for use in infants and children.
There is no evidence before me of the solubility either of divalent or of heptavalent manganese.
The new heptavalent conjugated pneumococcal vaccine should be given from two months of age.
Administration of trivalent licensed antitoxin or heptavalent botulinum may prevent or decrease a patient's progression to respiratory failure and hasten recovery.
Other